1.
Expression of the BRCA1、Bad、Rb in Breast Benign and Maligant Lesions;
BRCA1、Rb、Bad在乳腺良恶性病变中的表达
2.
Expressions of Livin and Smac in benign and malignant breast lesions
乳腺良、恶性病变组织中Livin和Smac的表达
3.
Gray scale contrast-enhanced ultrasound for differentiating benign from malignant breast lesions
乳腺良恶性病变的灰阶超声造影研究
4.
Approximately one third of all patients with malignant disease have hepatic metastasis.
在有恶性病变的全部病人中，大约1／3有肝转移。
5.
The Clinical Study of Benign and Malignant Breast Tumor with Multimodality MR Imaging;
磁共振多技术诊断乳腺良、恶性病变的临床研究
6.
The Study on the Relationship between the Expression of VEGF and Microvessel Density in the Begnign and Malignant Thyroid Neoplasms;
甲状腺良恶性病变VEGF表达及其MVD计数的研究
7.
Expression of P～（27）、PTEN、PCNA and TTF-1 in Benign and Malignant Thyroid Diseases;
P～（27）、PTEN、PCNA、TTF-1在甲状腺良恶性病变中的表达
8.
Phrosporylated SurvivinThr34 Express in Benign, Malignant Stomach Lesion;
磷酸化的survivinThr34蛋白在胃部良恶性病变中的表达
9.
Diagnostic Value of Enhanced CT Examination on Benign and Malignant Thyroid Lesions;
CT增强检查对甲状腺良恶性病变的诊断价值
10.
Expression and Significant of the PPARγ and PTEN in Breast Carcinoma and Benign Lesions
PPARγ和PTEN在乳腺良恶性病变中的表达及意义
11.
Expression of cytokeratin-19 and galectin-3 in thyroid lesions
CK19和Galectin-3在甲状腺良恶性病变中的表达
12.
Clinical evaluation of the efficacy and influencing factors for stent placement in treating malignant esophageal
食管恶性病变支架治疗后的中远期随访分析
13.
The clinical value of using enhanced CT in diagnosis of soft tissue benign and malignant lesions
CT增强鉴别软组织良恶性病变的临床价值
14.
Expression and clinical significance of Glypican-3 protein in benign and malignant disease of the liver
Glypican-3在肝脏良恶性病变中的表达及临床意义
15.
Clinicopathologic Analysis of Malignant Lymphoepithelial Lesions of the Parotid Gland;
腮腺恶性淋巴上皮病变临床病理分析
16.
Roles of CT and MRI in Differential Diagnosis of Pleural Disease;
CT与MRI对良、恶性胸膜病变的鉴别诊断
17.
A STUDY ON THE EVOLUTION OF STERIOD HORMONE RECEPTORS IN THE BENIGN AHD MALIGNANT BREAST LESIONS
乳腺良恶性疾病性激素受体演变机制初探
18.
31-phosphorus magnetic resonance spectroscopy in diagnosis of the benign and malignant masses in liver
~(31)P-MRS在肝脏良、恶性占位性病变中的诊断价值